immunity News and Research

RSS
Safety and immunogenicity of COVID-19 peptide vaccine

Safety and immunogenicity of COVID-19 peptide vaccine

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Study compares immune responses of patients with and without kidney failure after COVID-19 vaccination

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

Impeding SARS‑CoV‑2 evolution by targeting low-probability stochastic events

SARS-CoV-2 reinfection and the natural immune response

SARS-CoV-2 reinfection and the natural immune response

An assessment of potential epitopes in SARS-CoV-2 structural proteins

An assessment of potential epitopes in SARS-CoV-2 structural proteins

The antimicrobial properties of the lungfish cocoon

The antimicrobial properties of the lungfish cocoon

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Similar antibody responses to spike protein in COVID-19 survivors and vaccine recipients

Antibody persistence in infants after maternal COVID-19 vaccination

Antibody persistence in infants after maternal COVID-19 vaccination

Bat coronavirus ecology, evolution, and spillover

Bat coronavirus ecology, evolution, and spillover

Vaping linked to dysregulation of mitochondrial genes and immune response genes

Vaping linked to dysregulation of mitochondrial genes and immune response genes

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

Limited immune responses three months after Pfizer-BioNTech vaccination among elderly

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Vaccine-induced immune responses for SARS-CoV-2 in patients receiving anti-CD20 B-cell depleting therapies

Higher antibody level correlates with greater vaccine protection against COVID-19

Higher antibody level correlates with greater vaccine protection against COVID-19

Time of starting antiretroviral therapy can influence tumor development In HIV patients

Time of starting antiretroviral therapy can influence tumor development In HIV patients

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

Strong antibody responses against harmless coronaviruses may protect against SARS-CoV-2

LSHTM joins with YouTube and Klick Health to create 'Community Unity' for tackling vaccine misinformation

LSHTM joins with YouTube and Klick Health to create 'Community Unity' for tackling vaccine misinformation

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

Inactivated virion-based vaccine confers robust cell-mediated immunity against major SARS-CoV-2 variants

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

WHO’s C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

Interferon beta versus the SARS-CoV-2 Delta variant

Interferon beta versus the SARS-CoV-2 Delta variant

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

Preexisting rhinovirus infection and IFN induction in epithelium of asthma patients decreases SARS-CoV-2 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.